IMMX · Immix Biopharma, Inc. · Fails to Deliver
$8.05
-0.01 (-0.12%)
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company is unable to entirely fund these efforts with its current financial resources. If adequate funds are unavailable on a timely basis from operations or additional sources of financing, the Company may have to delay, reduce the scope of or eliminate one or more of its research or development programs which may materially and adversely affect its business, financial condition and operations.”View the 10-Q filed Aug 7, 2026
Market Cap
$576.61M
Shares
71.54M
Volume · Oct 27
1.15M
Avg daily vol (3M)
1.54M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-28 | 6,166 | $10.97 | $67,641 |
| 2026-09-21 | 1,987 | $12.50 | $24,838 |
| 2026-09-16 | 791 | $12.14 | $9,603 |
| 2026-09-15 | 934 | $12.21 | $11,404 |
| 2026-09-03 | 21,822 | $13.96 | $304,635 |
| 2026-09-01 | 770 | $14.03 | $10,803 |
| 2026-08-25 | 15 | $13.61 | $204 |
| 2026-08-24 | 478 | $13.66 | $6,529 |
| 2026-08-18 | 6,163 | $11.34 | $69,888 |
| 2026-08-13 | 1,188 | $11.37 | $13,508 |
| 2026-08-12 | 4,025 | $11.49 | $46,247 |
| 2026-08-11 | 1,675 | $10.13 | $16,968 |
Showing 1–12 of 12 settlements
Key facts
CIK
1873835
CUSIP
45258H106
13F (30d)
12 filings
12 filers
Visit website
Investor relations